FDA.reportPublic FDA data

2 ML Kedrab 150 UNT/ML Injection

RxCUI
1992536
RxNorm name
2 ML Kedrab 150 UNT/ML Injection
Display name
2 ML Kedrab 150 UNT/ML Injection
Full name
2 ML Kedrab 150 UNT/ML Injection
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:38:58

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
125613KedrabRabies Immune Globulin (Human)351(a)Rx2026-08-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
53f2a23b-c479-4c24-8cab-ee7a33a2633eKEDRAB 150 UNT/ML in 2 ML Injection [PSN] · 2 ML rabies immune globulin, human 150 UNT/ML Injection [Kedrab] [SBD] · 2 ML Kedrab 150 UNT/ML Injection [SY] · Kedrab 150 UNT/ML per 2 ML Injection [SY]47These highlights do not include all the information needed to use KEDRAB safely and effectively. See full prescribing information for KEDRAB. KEDRAB ® Rabies Immune Globulin (Human) solution for wound infiltration and intramuscular injection Initial U.S. Approval: 201720240221